Search results

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.medicine.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease-0 - 2026-07-11

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.stemcellcenter.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2026-07-11

For the second year in a row, Careers Centre at the Faculty has collaborated with Medicon Village to organize a Career Day for 170 life science students, including PhD students, and early career researchers. This year's Career Day took place at Medicon Village on December 5th. Last year proved successful and appreciated by both attendees, speakers and exhibiting companies. This year, plenary sessi

https://www.intramed.lu.se/en/article/career-day-2023-know-your-future-job-market - 2026-07-11

Two distinguished researchers at the Department of Physics have been promoted to professors at Lund University: David Silvermyr, specialising in high-energy heavy-ion physics, and Rainer Timm, an expert in surface physics. Their research spans from the most extreme states of matter to atomic-level interfaces in next-generation electronics. David Silvermyr – Exploring the most extreme states of mat

https://www.fysik.lu.se/en/article/quarks-nanostructures-two-physicists-appointed-professors-lund-university - 2026-07-11

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2026-07-11

Many believe that the profile areas initiative has been forgotten and is in hibernation, since the government has not reached a decision about a national effort. But that is not the case – at least not at Lund University. When I met the coordinators for the profile areas, they were all able to tell me about exciting new initiatives within research, education and external engagement. Here are a few

https://www.staff.lu.se/article/full-speed-ahead-profile-areas - 2026-07-12

This article is over 5 years old, and the information may therefore be outdated. During her PhD studies Sausan Moharram has been investigating the molecular mechanisms driving acute myeloid leukemia, shedding light on novel therapeutic approaches to treat this disease. Defending her PhD thesis on June 9th, in this interview Sausan tells us about her research within the Molecular Cancer Research gr

https://www.stemcellcenter.lu.se/article/phd-defence-interview-sausan-moharram - 2026-07-11

Is it possible to improve the antibodies that the body produces to fight SARS-CoV2? In a study led by researchers from Lund University in Sweden, this was investigated by redesigning antibodies and combining them against the virus. The modified antibodies have been tested in human cells and with mice. Many antibodies used to treat covid infection during the pandemic have been so-called neutralizin

https://www.medicine.lu.se/article/cocktail-modified-antibodies-provides-strong-effect-against-sars-cov-2 - 2026-07-11

År 2025 lämnar barn inom TEDDY-studien in de sista proverna på mottagningar i Sverige, Finland, Tyskland och USA. Den internationella studien har gett mycket ny kunskap om hur typ 1-diabetes utvecklas. Nu fortsätter analysarbetet med det långsiktiga målet att förebygga sjukdomen. Sverige och Finland är de två länder i världen som har högst andel barn som insjuknar i typ 1-diabetes, med hänsyn till

https://www.diabetesportalen.lu.se/artikel/ny-kunskap-om-typ-1-diabetes-snart-avslutas-jattestudien-teddy - 2026-07-11

Filipe Pereira and his research team have discovered a recipe on how to reprogram cancer cells into antigen-presenting dendritic cells, essential for initiating and enhancing anti-tumour immunity. This approach provides a promising strategy for cancer treatment. The goal of the now awarded project is to engineer the "vehicle" to deliver the instruction converting the cells, utilizing RNA vectors f

https://www.medicine.lu.se/article/professor-filipe-pereira-awarded-erc-proof-concept-grant - 2026-07-11

Filipe Pereira and his research team have discovered a recipe on how to reprogram cancer cells into antigen-presenting dendritic cells, essential for initiating and enhancing anti-tumour immunity. This approach provides a promising strategy for cancer treatment. The goal of the now awarded project is to engineer the "vehicle" to deliver the instruction converting the cells, utilizing RNA vectors f

https://www.stemcellcenter.lu.se/article/professor-filipe-pereira-awarded-erc-proof-concept-grant - 2026-07-11

Mats Paulssonstiftelserna delar i år ut anslag till åtta framstående forskningsprojekt varav sex projekt leds från Medicinska fakulteten. Projekten omfattar avancerade cancerbehandlingar, cellterapier, antibiotikaresistens och banbrytande diagnostik av Alzheimers sjukdom. Idag, vid en prisceremoni på Medicon Village, fick sex forskare från Medicinska fakulteten ta emot sina anslag. För första gång

https://www.medicin.lu.se/artikel/mats-paulssonstiftelser-anslar-15-miljoner-till-fakultetens-forskning - 2026-07-12

Lund University in Sweden has been awarded an EU grant of 8.3 million euros for a new international doctoral programme in regenerative medicine and advanced therapy medicinal products. The aim is to improve the environment for regenerative medicine and ATMPs in Europe and facilitate cooperation between research and clinical application. It started as an idea at the Lund Stem Cell Center to train a

https://www.medicine.lu.se/article/83-million-euros-doctoral-programme-regenerative-medicine-and-atmp - 2026-07-11

Lund University in Sweden has been awarded an EU grant of 8.3 million euros for a new international doctoral programme in regenerative medicine and advanced therapy medicinal products. The aim is to improve the environment for regenerative medicine and ATMPs in Europe and facilitate cooperation between research and clinical application. It started as an idea at the Lund Stem Cell Center to train a

https://www.stemcellcenter.lu.se/article/83-million-euros-doctoral-programme-regenerative-medicine-and-atmp - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. An international research team has discovered a treatment that dramatically reduces swelling after brain and spinal cord damage. By using an already approved drug on rats, the brain’s water channels could be manipulated with positive results. The new study offers hope to the millions of people who are affected by brai

https://www.science.lu.se/article/new-study-brains-water-channels-offers-hope-those-brain-and-spinal-cord-damage - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers at Lund University in Sweden have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development. The discovery is published in Nature Communica

https://www.lucc.lu.se/article/new-method-facilitates-development-antibody-based-drugs - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers at Lund University in Sweden have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development. The discovery is published in Nature Communica

https://www.medicine.lu.se/article/new-method-facilitates-development-antibody-based-drugs - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Carla Azevedo is set to defend her PhD thesis titled “Oligodendroglial (dys)function in alpha-synucleinopathies” on Thursday 30th of April. Here, Carla answers a few questions about her PhD journey at Lund Stem Cell Center, researching in the iPSC Laboratory for CNS disease modeling. How did you end up doing a PhD at

https://www.stemcellcenter.lu.se/article/thesis-defence-interview-carla-azevedo - 2026-07-11

Economic conditions influence whether and when people choose to have children. A new report from the Swedish government inquiry A Future with Children, led by LUSEM economist Åsa Hansson, shows how financial risks – particularly for women – may be contributing to declining birth rates. Fewer children are being born in Sweden, and economic conditions may play a larger role than previously assumed.

https://www.lusem.lu.se/article/economic-security-shapes-decisions-about-having-children - 2026-07-12

Professor Bo Norrving at Lund University has been awarded the World Federation of Neurology Award for Service to International Neurology, one of the highest international distinctions in the field. The award recognizes his decades-long contributions to stroke research, global health policy, and international leadership—work that has helped transform stroke from a neglected condition into a global

https://www.medicine.lu.se/article/bo-norrving-receives-prestigious-international-award-lifelong-service-neurology - 2026-07-11